Will Sébastien Bubeck leave OpenAI?
As of Fri, 20 Nov 2026 12:04:06 UTC, Kalshi traders price Yes (5.0%). The market has $1K in volume and closes on Fri, 08 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Yes | 5.0% | 5.0¢ | 95.0¢ |
Market details
- Venue: Kalshi
- Volume: $1K
- Liquidity: $1K
- Closes:
Resolution rules
If Sébastien Bubeck has either officially announced their intention to leave employment at OpenAI or has actually left employment at OpenAI after Issuance and before Jan 1, 2027, then the market resolves to Yes. An "official announcement" means a statement by the person themselves, their authorized representative, or the official body governing the office that the person will be departing from the office. Such announcements must be reported by at least one Source Agency to be considered official. The announcement must not specify they are leaving in more than a year from the statement, in which case the market does not resolve to Yes. "Leaving office" means the person no longer holds the office in any capacity, including but not limited to: resignation (effective), termination, removal, impeachment and removal, recall, or the expiration of their term without renewal. Temporary absences such as medical leave, suspension with possibility of return, or delegation of duties while retaining the office do NOT constitute leaving office. Forced departures (termination, impeachment and removal, etc.) satisfy the Payout Criterion even without a prior announcement. A change of team or job within OpenAI does NOT count as leaving employment at OpenAI.
Sources
Related markets
- Best AI at the end of 2026?
- When will Anthropic release Mythos?
- Which AI company will have the best coding model at the end of 2026?
- Which companies will have a top-ranked AI model this year?
- When will OpenAI achieve AGI?
- Where will Waymo operate this year?
More markets like this
- Will the FDA approve a cure for Type 1 diabetes before 2033?
- Will the FDA approve any psychedelic substance for medical use this year?
- Will the FDA approve CagriSema?
- Will the FDA approve retatrutide?
- Will the America Party contest the 2028 U.S. presidential election?
- Will the FDA approve VERVE-102?
- Will the OpenAI/Jony Ive device have a screen?
- Will the South Carolina special Republican primary be won outright?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.